Mutations in PI3K/AKT/mTOR pathway were reported frequently in advanced thyroid cancers (PDTC or ATC) especially in metastatic or recurrent cases, and also in follicular thyroid carcinomas [18,19]. The gene discussed is AKT1; the disease is thyroid gland carcinoma.